Y

CardioGen Pharma Investment Fund

Add to research

Index Performance

-1.37%
CardioGen Pharma Investment Fund
+3.76%
TMLARGE

Overview

Description

The pharmaceutical industry, particularly companies developing treatments for high lipoprotein(a) (Lp(a)), offers significant growth potential due to the increasing recognition of Lp(a) as a critical risk factor for cardiovascular diseases. Lp(a) is a genetic variant of LDL cholesterol that has been difficult to treat with conventional statins. Recent advancements in biotechnology and gene editing are driving the development of novel therapies specifically targeting Lp(a). The aging global population and rising awareness of preventive cardiovascular health also bolster demand. Additionally, regulatory support and lucrative market opportunities are incentivizing pharmaceutical companies to invest in research and development of innovative Lp(a)-lowering drugs. - [[Gene Editing Therapies]]: Focus on companies using CRISPR/Cas9 and other gene editing technologies to address genetic causes of high Lp(a). - [[mRNA-based Treatments]]: Investment in firms developing mRNA technology for targeted therapies aimed at reducing Lp(a) levels. - [[Apolipoprotein(a) Inhibitors]]: Companies involved in research and production of drugs that specifically inhibit the synthesis of apolipoprotein(a), a key component of Lp(a). - [[RNA Interference (RNAi) Drugs]]: Firms leveraging RNAi technology to silence genes responsible for the overproduction of lipoprotein(a). - [[Biologics and Monoclonal Antibodies]]: Investing in companies that are creating biologics or monoclonal antibodies to neutralize Lp(a) in the bloodstream. This index was generated with help from Thematic Analyst.

  • Inception Date07/25/2024
  • WeightingEqual
  • # of holdings8
What's inside?

Holdings

All holdings as of February 14, 2025
CSV download
Verve Therapeutics, Inc. (VERV)16.77%$726.42M120.24%74.45%-2.42
Amarin Corp. Plc (AMRN)14.94%$251.86M-34.93%36.70%-0.17
CRISPR Therapeutics AG (CRSP)13.70%$4.26B-89.95%-247.08%43.96
Arcturus Therapeutics Holdings, Inc. (ARCT)13.08%$488.93M-10.52%97.68%2.51
Eli Lilly & Co. (LLY)12.34%$801.48B32.00%82.54%N/A
Arrowhead Pharmaceuticals, Inc. (ARWR)11.51%$2.52B-29.60%-109.40%1,067.90
Ionis Pharmaceuticals, Inc. (IONS)9.77%$4.90B-7.21%95.09%6.79
Silence Therapeutics Plc (SLN)7.89%$225.83M-58.07%-142.91%33.19
Market data by FactSet
New feature

Thematic Research

View all of your research in one place. Toggle open the floating actions menu and click Open research sidebar to view your saved research for the current page.